Rhône-Poulenc Rorer Inc. regulatory update

Rhône-Poulenc Rorer Inc. The FDA approved RPR's Lovenox (enoxaparin sodium) to prevent deep vein thrombosis following knee replacement surgery. Lovenox is the first low molecular weight heparin appr...